BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36758305)

  • 1. Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist.
    Zang R; Xue L; Zhang M; Peng X; Li X; Du K; Shi C; Liu Y; Lin Y; Han W; Yu R; Wang Q; Yang J; Wang X; Jiang T
    Eur J Med Chem; 2023 Mar; 250():115184. PubMed ID: 36758305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists.
    Liu B; Tang L; Zhang X; Ma J; Sehgal M; Cheng J; Zhang X; Zhou Y; Du Y; Kulp J; Guo JT; Chang J
    Antiviral Res; 2017 Nov; 147():37-46. PubMed ID: 28982551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein Targets STING-Driven Antiviral Responses.
    Ullah TR; Balka KR; Ambrose RL; Pépin G; Wilce MCJ; Wilce JA; Thomas BJ; De Nardo D; Williams BRG; Gantier MP
    mBio; 2022 Aug; 13(4):e0206422. PubMed ID: 35924852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of (-)-Epigallocateshin gallate derivatives promoting innate immune activation via 2',3'-cyclic GMP-AMP-stimulator of interferon genes pathway.
    Lee H; Jeong JH; Lee T; Chong Y; Choo H; Lee S
    Bioorg Med Chem Lett; 2023 Jun; 90():129325. PubMed ID: 37182610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGAS-STING signaling.
    Sun Z; Hornung V
    Curr Biol; 2022 Jul; 32(13):R730-R734. PubMed ID: 35820380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress on the activation of the cGAS-STING pathway and its regulation by biomolecular condensation.
    Yu X; Zhao Z; Jiang Z
    J Mol Cell Biol; 2022 Nov; 14(6):. PubMed ID: 35803579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.
    Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR
    PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMPDL3A is a cGAMP-degrading enzyme induced by LXR-mediated lipid metabolism to restrict cGAS-STING DNA sensing.
    Hou Y; Wang Z; Liu P; Wei X; Zhang Z; Fan S; Zhang L; Han F; Song Y; Chu L; Zhang C
    Immunity; 2023 Nov; 56(11):2492-2507.e10. PubMed ID: 37890481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-nucleotide agonist that binds covalently to cysteine residues of STING.
    Matsumoto K; Ni S; Arai H; Toyama T; Saito Y; Suzuki T; Dohmae N; Mukai K; Taguchi T
    Cell Struct Funct; 2023 Feb; 48(1):59-70. PubMed ID: 36575042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking STING as a Therapeutic Antiviral Strategy.
    Paulis A; Tramontano E
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA.
    Kato K; Omura H; Ishitani R; Nureki O
    Annu Rev Biochem; 2017 Jun; 86():541-566. PubMed ID: 28399655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of innate immunity by the cGAS-STING pathway.
    Mosallanejad K; Kagan JC
    Immunol Cell Biol; 2022 Jul; 100(6):409-423. PubMed ID: 35485309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cGAS-STING signalling in cancer: Approach for combination therapy.
    Vasiyani H; Wadhwa B; Singh R
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188896. PubMed ID: 37088059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular functions of cGAS-STING signaling.
    Chen C; Xu P
    Trends Cell Biol; 2023 Aug; 33(8):630-648. PubMed ID: 36437149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity.
    Tabar MMM; Fathi M; Kazemi F; Bazregari G; Ghasemian A
    Mol Biol Rep; 2024 Apr; 51(1):487. PubMed ID: 38578532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of STING Based on Its Structural Features.
    Hussain B; Xie Y; Jabeen U; Lu D; Yang B; Wu C; Shang G
    Front Immunol; 2022; 13():808607. PubMed ID: 35928815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases.
    Pan J; Fei CJ; Hu Y; Wu XY; Nie L; Chen J
    Zool Res; 2023 Jan; 44(1):183-218. PubMed ID: 36579404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cGAS/STING signaling and corresponding immune escape strategies of viruses.
    Ge Z; Ding S
    Front Cell Infect Microbiol; 2022; 12():954581. PubMed ID: 36189363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.